Literature DB >> 8228129

A prospective study of bacterial infections in patients with cirrhosis.

W R Caly1, E Strauss.   

Abstract

One hundred and seventy hospitalized patients with cirrhosis were included in a prospective and sequential study, to verify the prevalence and most frequent causes of bacterial infection. The differences in clinical and laboratory data between the two groups were analyzed: group I--80 patients who developed bacterial infection and group II--90 patients without bacterial infection. The prevalence or cumulative frequency of the development of bacterial infection during one hospitalization was 47.06%. Among these, the most frequent types of infection were: spontaneous bacterial peritonitis (SBP): 31.07%, urinary tract infection (UTI): 25.24% and pneumonia: 21.37%. Community infections were more frequent (56.25%) than nosocomial infections (32.50%) and they occurred sequentially in 11.25% of the cases. The agents responsible were gram negative bacteria in 72.34% of the cases. Clinical and biochemical parameters in bacterial infection were generally correlated with the severity of liver disease. Child-Pugh classification showed a predominance of class C in infected cirrhotic patients compared to non-infected ones. During hospitalization, the mortality rate of group I was 30% whereas in group II it was 5.55% (P = 0.0001). SBP and pneumonia were the most severe types of infection, with high mortality rates, 31.25% and 40.91%, respectively. These results indicate that bacterial infection is a severe complication in the course of cirrhosis.

Entities:  

Mesh:

Year:  1993        PMID: 8228129     DOI: 10.1016/s0168-8278(05)80280-6

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  122 in total

Review 1.  Nitric oxide in patients with cirrhosis and bacterial infections.

Authors:  José Such; Rubén Francés; Miguel Pérez-Mateo
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

2.  Bacterial infections other than spontaneous bacterial peritonitis in cirrhosis.

Authors:  Chalermrat Bunchorntavakul; Disaya Chavalitdhamrong
Journal:  World J Hepatol       Date:  2012-05-27

Review 3.  Inflammation: A novel target of current therapies for hepatic encephalopathy in liver cirrhosis.

Authors:  Ming Luo; Jian-Yang Guo; Wu-Kui Cao
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

Review 4.  Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.

Authors:  Mary D Cannon; Paul Martin; Andres F Carrion
Journal:  Dig Dis Sci       Date:  2020-01       Impact factor: 3.199

5.  Spontaneous fungal peritonitis: a severe complication in patients with advanced liver cirrhosis.

Authors:  S Y Hwang; S J Yu; J-H Lee; J S Kim; J W Yoon; Y J Kim; J-H Yoon; E-C Kim; H-S Lee
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-02       Impact factor: 3.267

6.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

7.  Clostridium sp. bacteremia in a cirrhotic patient with an unresecable hepatocellular carcinoma: as fatal as we thought?

Authors:  Helena Masnou; Vicente Lorenzo-Zúñiga; Eva Erice Muñoz; Ramón Planas; Miquel Angel Gassull
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

8.  Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost.

Authors:  Patrick G Northup; Michael M Abecassis; Michael J Englesbe; Jean C Emond; Vanessa D Lee; George J Stukenborg; Lan Tong; Carl L Berg
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

Review 9.  Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding.

Authors:  Yeong Yeh Lee; Hoi-Poh Tee; Sanjiv Mahadeva
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

10.  Diagnosis and management of bacterial infections in decompensated cirrhosis.

Authors:  Maria Pleguezuelo; Jose Manuel Benitez; Juan Jurado; Jose Luis Montero; Manuel De la Mata
Journal:  World J Hepatol       Date:  2013-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.